Mix-Zones as an Effective Privacy Enhancing Technique in Mobile and Vehicular Ad-hoc Networks.

Autor: Ravi, Nirupama¹ (AUTHOR) nirupamaravi@umass.edu, Krishna, C. Mani² (AUTHOR) krishna@ecs.umass.edu, Koren, Israel² (AUTHOR) koren@ecs.umass.edu

Publikováno v: ACM Computing Surveys. Dec2024, Vol. 56 Issue 12, p1-33. 33p.

Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 study.

Autor: Maddeppungeng M; Department of Pediatrics, Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia.; Department of Pediatrics, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia., Nurdin A; Department of Pediatrics, Faculty of Medicine, Universitas Andalas, Padang, Indonesia.; Department of Pediatrics, Dr. M. Djamil Hospital Padang, Kota Padang, Indonesia., Nency YM; Department of Child Health, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia., Sekartini R; Department of Child Health, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia., Medise BE; Department of Child Health, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia., Soedjatmiko S; Department of Child Health, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia., Massi MN; Department of Clinical Microbiology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.; Institute for Research and Community Services, Universitas Hasanuddin, Makassar, Indonesia., Darma S; Department of Pediatrics, Universitas Muslim Indonesia, Makassar, Indonesia., Darussalam AHE; Department of Pediatrics, Universitas Muslim Indonesia, Makassar, Indonesia., Ramadhani N; Department of Pediatrics, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia., Hidayah N; Institute for Research and Community Services, Universitas Hasanuddin, Makassar, Indonesia., Chalid MT; Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia., Ramadany S; Department of Public Health and Community Medicine, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia., Wahyuni S; Department of Parasitology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia., Djaharuddin I; Department of Pulmonology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.; Department of Pulmonology, Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia., Santoso A; Department of Pulmonology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.; Department of Pulmonology, Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia., Fikri B; Department of Pediatrics, Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia.; Department of Pediatrics, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia., Alimuddin S; Department of Internal Medicine, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia., Pelupessy NM; Department of Pediatrics, Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia.; Department of Pediatrics, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia., Masadah R; Department of Anatomical Pathology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia., Putri AZ; PT Bio Farma, Bandung, Indonesia., Setyaningsih L; PT Bio Farma, Bandung, Indonesia., Yani FF; Department of Pediatrics, Faculty of Medicine, Universitas Andalas, Padang, Indonesia.; Department of Pediatrics, Dr. M. Djamil Hospital Padang, Kota Padang, Indonesia., Anggrainy F; Department of Pulmonology and Respiratory Medicine, Dr. M. Djamil Hospital Padang, Kota Padang, Indonesia.; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Andalas, Padang, Indonesia., Deza PA; Department of Pediatrics, Faculty of Medicine, Universitas Andalas, Padang, Indonesia., Maharani N; Department of Pharmacology and Therapeutics, Faculty of Medicine Universitas Diponegoro, Semarang, Indonesia., Mahati E; Department of Pharmacology and Therapeutics, Faculty of Medicine Universitas Diponegoro, Semarang, Indonesia., Hapsari R; Department of Microbiology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia., Farhanah N; Department of Internal Medicine, Faculty of Medicine, Universitas Diponegoro. Semarang, Indonesia., Pramudo SG; Department of Internal Medicine, Faculty of Medicine, Universitas Diponegoro. Semarang, Indonesia., Tri Anantyo D; Department of Internal Medicine, Faculty of Medicine, Universitas Diponegoro. Semarang, Indonesia.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2429231. Date of Electronic Publication: 2024 Dec 05.

Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines.

Autor: Wanlapakorn N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Sarawanangkoor N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Srimuan D; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Thatsanathorn T; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Thongmee T; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Poovorawan Y; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2352909. Date of Electronic Publication: 2024 May 16.

Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques.

Autor: Abhyankar MM; Division of Infectious Diseases and International Health, School of Medicine, University of Virginia Health System, Charlottesville, VA, USA., Xu F; Division of Infectious Diseases and International Health, School of Medicine, University of Virginia Health System, Charlottesville, VA, USA., Chavez D; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Goodroe A; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Mendoza E; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Chen C; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Singh DK; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Varnador F Jr; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Sivananthan SJ; Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA., Kinsey R; Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA., Lykins WR; Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA., Murphy BM; Department of Mechanical Engineering, University of Alberta, Edmonton, AB, Canada., Martin AR; Department of Mechanical Engineering, University of Alberta, Edmonton, AB, Canada., Tomai MA; Contract Employee for 3M Healthcare, Saint Paul, MN, USA., Ghosal S; Division of Biostatistics, Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, VA, USA., Casper C; Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Pedersen K; Process Development, TechLab Inc, Blacksburg, VA, USA., Petri WA Jr; Division of Infectious Diseases and International Health, School of Medicine, University of Virginia Health System, Charlottesville, VA, USA., Fox CB; Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2374147. Date of Electronic Publication: 2024 Aug 01.

Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer.

Autor: Qiu MZ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, PR China. qiumzh@sysucc.org.cn.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, PR China. qiumzh@sysucc.org.cn., Bai Y; Department of Gastroenterology 1, Harbin Medical University Cancer Hospital, Harbin, PR China., Wang J; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, PR China., Gu K; Oncology Ward 1, The First Affiliated Hospital of Anhui Medical University, Hefei, PR China., Yang M; Gastroenterology Ward (2), Shanxi Provincial Cancer Hospital, Taiyuan, PR China., He Y; Medical Oncology Ward 1, Anhui Provincial Cancer Hospital, Hefei, PR China., Yi C; Abdominal Oncology, West China Hospital of Sichuan University, Chengdu, PR China., Jin Y; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science & Technology of China, Chengdu, PR China., Liu B; Gastroenterology Ward 3, Cancer Hospital Affiliated to Shandong First Medical University, Jinan, PR China., Wang F; Oncology Department 1, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China., Chen YK; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, PR China.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, PR China., Dai W; Clinical Research & Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, PR China., Jiang Y; Clinical Research & Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, PR China., Huang C; Clinical Research & Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, PR China., Xu RH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, PR China. xurh@sysucc.org.cn.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, PR China. xurh@sysucc.org.cn., Luo HY; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, PR China. luohy@sysucc.org.cn.; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, PR China. luohy@sysucc.org.cn.

Publikováno v: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Dec 16; Vol. 9 (1), pp. 349. Date of Electronic Publication: 2024 Dec 16.